Search research articles
Contact Us
Filters
Showing results (421-430 of 473) with videos related to
Page
of 48
Sort By:
Leukemia
|
April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
J F Nomdedéu, M Hoyos, M Carricondo, et al.
Actas Dermo-Sifiliograficas
|
July 16, 2017
Guidelines on the Use of Methotrexate in Psoriasis
G Carretero, L Puig, L Dehesa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol
Iván Alvarez, Anna Sureda, Maria D Caballero, et al.
Blood
|
April 16, 2010
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Miguel A Sanz, Pau Montesinos, Chelo Rayón, et al.
Actas Dermo-Sifiliograficas
|
September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]
G Carretero, L Puig, L Dehesa, et al.
Medicina Clinica
|
May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]
C Rozman, E Carreras, J Sierra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
M Spina, Z Nagy, J M Ribera, et al.
Blood
|
August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
M A Sanz, F Lo Coco, G Martín, et al.
Leukemia
|
November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S de Botton, M A Sanz, S Chevret, et al.
British Journal of Haematology
|
September 15, 2007
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes
Karl S Peggs, Anna Sureda, Wendi Qian, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 473) with videos related to
Sort By:
Page
of 48
Leukemia
|
April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
J F Nomdedéu, M Hoyos, M Carricondo, et al.
Actas Dermo-Sifiliograficas
|
July 16, 2017
Guidelines on the Use of Methotrexate in Psoriasis
G Carretero, L Puig, L Dehesa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol
Iván Alvarez, Anna Sureda, Maria D Caballero, et al.
Blood
|
April 16, 2010
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Miguel A Sanz, Pau Montesinos, Chelo Rayón, et al.
Actas Dermo-Sifiliograficas
|
September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]
G Carretero, L Puig, L Dehesa, et al.
Medicina Clinica
|
May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]
C Rozman, E Carreras, J Sierra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
M Spina, Z Nagy, J M Ribera, et al.
Blood
|
August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
M A Sanz, F Lo Coco, G Martín, et al.
Leukemia
|
November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S de Botton, M A Sanz, S Chevret, et al.
British Journal of Haematology
|
September 15, 2007
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes
Karl S Peggs, Anna Sureda, Wendi Qian, et al.
Page
of 48